Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Modulation of CD4+ T Helper Cell Memory Responses in the Human Skin.

Padovan E.

Int Arch Allergy Immunol. 2017;173(3):121-137. doi: 10.1159/000477728. Epub 2017 Aug 9. Review.

2.

Associate Editor Elisabetta Padovan.

Padovan E.

Int Arch Allergy Immunol. 2016;171(3-4):291. doi: 10.1159/000453536. Epub 2017 Jan 4. No abstract available.

3.

Editorial: Innate Immune Cell Determinants of T Cell Immunity: From Basic Mechanisms to Clinical Implications.

Padovan E, Martin SF.

Front Immunol. 2016 Jan 14;6:664. doi: 10.3389/fimmu.2015.00664. eCollection 2015. No abstract available.

4.

Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.

Amicarella F, Muraro MG, Hirt C, Cremonesi E, Padovan E, Mele V, Governa V, Han J, Huber X, Droeser RA, Zuber M, Adamina M, Bolli M, Rosso R, Lugli A, Zlobec I, Terracciano L, Tornillo L, Zajac P, Eppenberger-Castori S, Trapani F, Oertli D, Iezzi G.

Gut. 2017 Apr;66(4):692-704. doi: 10.1136/gutjnl-2015-310016. Epub 2015 Dec 30.

5.

Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis.

Däster S, Eppenberger-Castori S, Hirt C, Soysal SD, Delko T, Nebiker CA, Weixler B, Amicarella F, Iezzi G, Governa V, Padovan E, Mele V, Sconocchia G, Heberer M, Terracciano L, Kettelhack C, Oertli D, Spagnoli GC, von Holzen U, Tornillo L, Droeser RA.

Oncoimmunology. 2015 May 29;4(12):e1050574. eCollection 2015 Dec.

6.

Blocking of LFA-1 enhances expansion of Th17 cells induced by human CD14(+) CD16(++) nonclassical monocytes.

Traunecker E, Gardner R, Fonseca JE, Polido-Pereira J, Seitz M, Villiger PM, Iezzi G, Padovan E.

Eur J Immunol. 2015 May;45(5):1414-25. doi: 10.1002/eji.201445100. Epub 2015 Mar 24.

7.

Anti-inflammatory/tissue repair macrophages enhance the cartilage-forming capacity of human bone marrow-derived mesenchymal stromal cells.

Sesia SB, Duhr R, Medeiros da Cunha C, Todorov A, Schaeren S, Padovan E, Spagnoli G, Martin I, Barbero A.

J Cell Physiol. 2015 Jun;230(6):1258-69. doi: 10.1002/jcp.24861.

PMID:
25413299
8.

GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer.

Nebiker CA, Han J, Eppenberger-Castori S, Iezzi G, Hirt C, Amicarella F, Cremonesi E, Huber X, Padovan E, Angrisani B, Droeser RA, Rosso R, Bolli M, Oertli D, von Holzen U, Adamina M, Muraro MG, Mengus C, Zajac P, Sconocchia G, Zuber M, Tornillo L, Terracciano L, Spagnoli GC.

Clin Cancer Res. 2014 Jun 15;20(12):3094-106. doi: 10.1158/1078-0432.CCR-13-2774. Epub 2014 Apr 15.

9.

Limiting dilution analysis of antigen-specific T cells.

Carneiro J, Duarte L, Padovan E.

Methods Mol Biol. 2009;514:95-105. doi: 10.1007/978-1-60327-527-9_7.

PMID:
19048215
10.

Visualizing CTL/melanoma cell interactions: multiple hits must be delivered for tumour cell annihilation.

Caramalho I, Faroudi M, Padovan E, Müller S, Valitutti S.

J Cell Mol Med. 2009 Sep;13(9B):3834-46. doi: 10.1111/j.1582-4934.2008.00586.x. Epub 2008 Oct 6.

11.

Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists.

Kamgang RK, Ramos I, Rodrigues Duarte L, Ghielmetti M, Freudenberg M, Dahinden C, Padovan E.

Med Microbiol Immunol. 2008 Dec;197(4):369-79. doi: 10.1007/s00430-008-0081-6. Epub 2008 Feb 19.

12.

How pattern recognition receptor triggering influences T cell responses: a new look into the system.

Padovan E, Landmann RM, De Libero G.

Trends Immunol. 2007 Jul;28(7):308-14. Epub 2007 May 29.

PMID:
17537673
13.

Adjuvanticity of microbial-derived particles and synthetic analogs in vitro.

Padovan E.

ALTEX. 2007;24 Spec No:96-7. No abstract available.

PMID:
19835078
14.

Synthetic bacterial lipopeptide analogs: structural requirements for adjuvanticity.

Ghielmetti M, Reschner A, Zwicker M, Padovan E.

Immunobiology. 2005;210(2-4):211-5. Review.

PMID:
16164028
15.

Synthetic bacterial lipopeptide analogs facilitate naive CD4+ T cell differentiation and enhance antigen-specific HLA-II-restricted responses.

Ghielmetti M, Zwicker M, Ghielmetti T, Simon MM, Villiger PM, Padovan E.

Eur J Immunol. 2005 Aug;35(8):2434-42.

16.

Influenza virosomes enhance class I restricted CTL induction through CD4+ T cell activation.

Schumacher R, Adamina M, Zurbriggen R, Bolli M, Padovan E, Zajac P, Heberer M, Spagnoli GC.

Vaccine. 2004 Jan 26;22(5-6):714-23.

PMID:
14741164
17.

Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes.

Adamina M, Bolli M, Albo F, Cavazza A, Zajac P, Padovan E, Schumacher R, Reschner A, Feder C, Marti WR, Oertli D, Heberer M, Spagnoli GC.

Br J Cancer. 2004 Jan 12;90(1):263-9.

18.

Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients.

Zajac P, Oertli D, Marti W, Adamina M, Bolli M, Guller U, Noppen C, Padovan E, Schultz-Thater E, Heberer M, Spagnoli G.

Hum Gene Ther. 2003 Nov 1;14(16):1497-510.

PMID:
14577912
19.

The ester-bonded palmitoyl side chains of Pam3CysSerLys4 lipopeptide account for its powerful adjuvanticity to HLA class I-restricted CD8+ T lymphocytes.

Reschner A, Moretta A, Landmann R, Heberer M, Spagnoli GC, Padovan E.

Eur J Immunol. 2003 Jul;33(7):2044-52.

20.

Interferon-a sensitivity in melanoma cells: detection of potential response marker genes.

Certa U, Seiler M, Padovan E, Spagnoli GC.

Recent Results Cancer Res. 2002;160:85-91.

PMID:
12079243
21.

Cytotoxic T-cell induction in metastatic melanoma patients undergoing recombinant vaccinia virus-based immuno-gene therapy.

Spagnoli GC, Zajac P, Marti WR, Oertli D, Padovan E, Noppen C, Kocher T, Adamina M, Heberer M.

Recent Results Cancer Res. 2002;160:195-201.

PMID:
12079214
22.

Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells.

Padovan E, Terracciano L, Certa U, Jacobs B, Reschner A, Bolli M, Spagnoli GC, Borden EC, Heberer M.

Cancer Res. 2002 Jun 15;62(12):3453-8.

23.
24.

Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo.

Oertli D, Marti WR, Zajac P, Noppen C, Kocher T, Padovan E, Adamina M, Schumacher R, Harder F, Heberer M, Spagnoli GC.

Hum Gene Ther. 2002 Mar 1;13(4):569-75.

PMID:
11874634
25.

B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.

Girard T, Cavagna D, Padovan E, Spagnoli G, Urwyler A, Zorzato F, Treves S.

J Biol Chem. 2001 Dec 21;276(51):48077-82. Epub 2001 Oct 22. Erratum in: J Biol Chem 2002 Apr 19;277(16):14350.

26.

Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.

Schütz A, Oertli D, Marti WR, Noppen C, Padovan E, Spagnoli GC, Heberer M, Zajac P.

Cancer Gene Ther. 2001 Sep;8(9):655-61.

27.
28.

Modulation of dendritic cell phenotype and mobility by tumor cells in vitro.

Remmel E, Terracciano L, Noppen C, Zajac P, Heberer M, Spagnoli GC, Padovan E.

Hum Immunol. 2001 Jan;62(1):39-49.

PMID:
11165714
29.

Antigen-dependent and -independent IFN-gamma modulation by penicillins.

Padovan E, von Greyerz S, Pichler WJ, Weltzien HU.

J Immunol. 1999 Jan 15;162(2):1171-7.

30.
31.

T-cell response in penicillin allergy.

Padovan E.

Clin Exp Allergy. 1998 Sep;28 Suppl 4:33-6. Review.

PMID:
9761028
32.

Molecular features of penicillin allergy.

Weltzien HU, Padovan E.

J Invest Dermatol. 1998 Mar;110(3):203-6. Review.

33.

Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy.

Padovan E, Bauer T, Tongio MM, Kalbacher H, Weltzien HU.

Eur J Immunol. 1997 Jun;27(6):1303-7.

PMID:
9209477
34.

Cross-reactivity of T cell lines and clones to beta-lactam antibiotics.

Mauri-Hellweg D, Zanni M, Frei E, Bettens F, Brander C, Mauri D, Padovan E, Weltzien HU, Pichler WJ.

J Immunol. 1996 Aug 1;157(3):1071-9.

PMID:
8757611
35.

T cell immune responses to haptens. Structural models for allergic and autoimmune reactions.

Weltzien HU, Moulon C, Martin S, Padovan E, Hartmann U, Kohler J.

Toxicology. 1996 Feb 22;107(2):141-51. Review.

PMID:
8599173
36.

T cell recognition of penicillin G: structural features determining antigenic specificity.

Padovan E, Mauri-Hellweg D, Pichler WJ, Weltzien HU.

Eur J Immunol. 1996 Jan;26(1):42-8.

PMID:
8566082
37.

Dual receptor T-cells. Implications for alloreactivity and autoimmunity.

Padovan E, Casorati G, Dellabona P, Giachino C, Lanzavecchia A.

Ann N Y Acad Sci. 1995 Jul 7;756:66-70. Review.

PMID:
7645875
39.

Serial triggering of many T-cell receptors by a few peptide-MHC complexes.

Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A.

Nature. 1995 May 11;375(6527):148-51.

PMID:
7753171
40.

Normal T lymphocytes can express two different T cell receptor beta chains: implications for the mechanism of allelic exclusion.

Padovan E, Giachino C, Cella M, Valitutti S, Acuto O, Lanzavecchia A.

J Exp Med. 1995 Apr 1;181(4):1587-91.

41.

kappa+lambda+ dual receptor B cells are present in the human peripheral repertoire.

Giachino C, Padovan E, Lanzavecchia A.

J Exp Med. 1995 Mar 1;181(3):1245-50.

42.

An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells.

Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A.

J Exp Med. 1994 Sep 1;180(3):1171-6.

43.

Expression of two T cell receptor alpha chains: dual receptor T cells.

Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A.

Science. 1993 Oct 15;262(5132):422-4.

PMID:
8211163
44.

Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation.

Lane P, Brocker T, Hubele S, Padovan E, Lanzavecchia A, McConnell F.

J Exp Med. 1993 Apr 1;177(4):1209-13.

45.

Ion channel and membrane translocation of diphtheria toxin.

Montecucco C, Papini E, Schiavo G, Padovan E, Rossetto O.

FEMS Microbiol Immunol. 1992 Sep;5(1-3):101-11. Review.

PMID:
1384590
46.

Determination of diphtheria toxin neutralizing antibody titers with a cell protein synthesis inhibition assay.

Padovan E, Papini E, Rappuoli R, Montecucco C.

Med Microbiol Immunol. 1991;180(1):29-35.

PMID:
2056964

Supplemental Content

Loading ...
Support Center